NHS Genomic Medicine Service - delivering personalised cancer services in testing times (In association with Bayer)
- Evaluate progress against NHS LTP ambitions to offer routine genomic testing to 100,000 patients with newly diagnosed advanced cancers per year by 2023
- Understand how Genomic Laboratory Hubs are working to deliver equitable, timely and consistent access to high quality genomic testing across England
- Demonstrate the role and value of precision cancer diagnosis and treatments in improving patient care and creating less demand on the system
- Learn about the challenges faced by cellular and molecular pathology services and how they need to evolve to support improved precision cancer diagnosis and treatment
This webinar event is funded by Bayer. Wilmington Healthcare/the Health Service Journal has worked with Bayer to develop the agenda and identify speakers for this webinar as part of the HSJ Cancer Virtual Series.
